Abstract:Type 2 diabetes interferes with bone remodeling mechanisms, requiring studies to reverse this damage, and resveratrol is a polyphenol with rich properties. This study aimed to characterize the long bone morphology and peri-implant biomechanics of normoglycemic and type 2 diabetic animals treated with resveratrol. Thirty-two male Wistar rats were used and divided into normoglycemic and diabetic with or without treatment. They had the installation of implants in the tibia and treatment with oral resveratrol within 45 days. Resveratrol was responsible for weight homeostasis and decreased glycemic levels in rats with type 2 diabetes. The three-point bending testing, resveratrol showed positive effects on the biomechanics of long bones, corroborating a more resistant bone in comparison to untreated diabetics. Micro-ct revealed how bone metabolism is affected by systemic disease, decreasing bone quality. The counter-torque of normoglycemic animals showed superior osseointegration to diabetes, with no differences in the administration of the polyphenol, showing the sovereignty of the deleterious effects of the disease when there is a tissue lesion and an inflammatory picture installed. Overall, resveratrol acted positively in the etiopathogenesis of type 2 diabetes and revealed positive effects on the strength of long bones.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the effects of resveratrol on the long - bone morphology and biomechanical characteristics of bone repair around implants in type 2 diabetic rats. Specifically, the study aims to evaluate whether resveratrol can improve the problems of bone mass and bone strength decline caused by type 2 diabetes by comparing the long - bone morphological characteristics and biomechanical properties around implants in normoglycemic and type 2 diabetic rats with or without resveratrol treatment. ### Research Background Type 2 diabetes is a global public health problem, affecting 463 million people, of which 50.1% of adults are undiagnosed, and 90 - 95% of patients have type 2 diabetes. Type 2 diabetes not only affects the cardiovascular, retina, kidney and nervous systems, but also affects bone health, leading to a decline in bone mass and bone strength and increasing the risk of fractures. High blood - glucose levels can damage the bone mineral matrix, change cell function and bone remodeling, and accumulate advanced glycation end products (AGEs), resulting in the degradation of collagen and changes in bone microstructure. ### Research Objectives The main objectives of the study are: 1. **Evaluate the effects of resveratrol on the long - bone morphology and biomechanical characteristics of type 2 diabetic rats**: By comparing the long - bone morphological characteristics and biomechanical properties in normoglycemic and type 2 diabetic rats with or without resveratrol treatment, explore whether resveratrol can improve the problems of bone mass and bone strength decline caused by type 2 diabetes. 2. **Analyze the effects of resveratrol on bone repair around implants**: Through biomechanical tests around implants, evaluate whether resveratrol can promote osseointegration and repair in type 2 diabetic rats. ### Methods - **Animal models**: Use 32 male Wistar rats and divide them into four groups: normoglycemic group (NG), normoglycemic + resveratrol group (NGrvt), type 2 diabetic group (T2D) and type 2 diabetic + resveratrol group (T2Drvt). - **Type 2 diabetes induction**: Induce type 2 diabetes by high - fat diet and low - dose streptozotocin (STZ) injection. - **Resveratrol treatment**: Start from the confirmation of type 2 diabetes and last for 45 days, with an oral dose of 100 mg/kg resveratrol per day. - **Implant surgery**: Install a titanium alloy implant in the left tibia, and conduct biomechanical tests 30 days after the operation. - **Biomechanical tests**: Include three - point bending test and reverse - torque test. - **Micro - CT analysis**: Evaluate the microstructure parameters of trabecular bone and cortical bone. ### Results - **Body weight and blood - glucose levels**: The body weight and blood - glucose levels in the resveratrol - treated groups were effectively controlled. - **Three - point bending test**: Resveratrol treatment significantly increased the bone strength of type 2 diabetic rats, showing higher maximum force and breaking force. - **Micro - CT analysis**: The percentage of trabecular bone volume and the structural model index in the resveratrol - treated groups were improved, and the porosity of cortical bone was decreased. - **Reverse - torque test**: The reverse - torque value in the normoglycemic group was significantly higher than that in the type 2 diabetic group, but resveratrol treatment had no significant effect on the reverse - torque value of type 2 diabetic rats. ### Discussion The research results show that resveratrol has a positive impact on the bone mass and bone strength of type 2 diabetic rats, especially in improving bone strength and trabecular bone structure. These findings provide a scientific basis for resveratrol as an adjuvant treatment for type 2 diabetes. However, for type 2 diabetic rats with already occurred tissue damage and inflammatory reactions, the treatment effect of resveratrol is limited, which may be related to the pathophysiological process of the disease.

Morphological and biomechanical characterization of long bones and peri-implant bone repair in type 2 diabetic rats treated with resveratrol